AI for drug formulation
Lavo Life Sciences runs simulations of drug molecules on computers. Pharma companies use these simulations to guide their experiments and ultimately save time and money in the lab. This will de-risk and expedite clinical trials and FDA approval.
What they do:
Artificial intelligence for drug discovery.
Quick facts:
HQ: San Francisco, CA, United States
Funding:
$19.8M · Equity · Mar 2026
What they do:
Multi-targeted therapeutics to treat complex diseases
Quick facts:
HQ: New York, NY, United States
What they do:
Gen AI molecular simulations that reproduce wetlab results
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Using the immune system to cure disease
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Using CRISPR to find treatments for cancer and inflammation
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Generative AI for protein design
Quick facts:
HQ: San Francisco, CA, United States
AI for drug formulation
3 employees, according to the company profile.
There are no funding rounds for Lavo Life Sciences in our data.
Similar startups: Numerion Labs, Harmonic Discovery, and Ångström AI.